Support Your Local Talent
854 posts





Downed US pilot interviewed by Fox News



🚨 BREAKING NEWS: Trump posts a video with a CGI Earth and talks about lies traveling fast. If he’s signaling the NASA Moon hoax, MAGA will erupt, Russia/China/India won’t sleep, history gets interesting — and $100B could be saved. Is he finally ready to tell the truth? 🌕👀









🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️ We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology. This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate). Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day. The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery. At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]): ✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%) ✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%) ✅ 36.1% reported stable disease (95% CI: 28.1–44.9%) Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months. The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events. Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach. Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies. Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary. This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes. The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.” @twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson



Hydrogen Peroxide Destroys Bacteria, Viruses, Yeast, Spores and Fungi, According to CDC!! What is Hydrogen Peroxide? It (H2O2) is a chemical compound composed of two hydrogen atoms and two oxygen atoms. It is a pale blue liquid in its pure form but appears colorless when diluted. Hydrogen peroxide is commonly available in concentrations ranging from 3% for household use to 35% for industrial applications. It is a versatile disinfectant due to its ability to produce reactive oxygen species that can attack and destroy various pathogens. How Does It Work? Hydrogen peroxide works by releasing oxygen molecules when it comes into contact with organic material. This release of oxygen creates a highly reactive environment that can damage the cell walls of microorganisms, leading to their inactivation. Here’s how it affects different types of pathogens: 🦠 Bacteria: It can penetrate bacterial cell walls, leading to oxidative stress that damages essential cellular components, ultimately causing cell death. 🦠Viruses: It disrupts the viral envelope or capsid, rendering the virus inactive and unable to infect host cells. 🦠Spores: Spores are highly resistant forms of bacteria or fungi. Hydrogen peroxide can penetrate the tough outer layers of spores, leading to their inactivation. 🦠Yeast and Fungi: Similar to bacteria, the disinfectant disrupts the cell walls of yeast and fungi, leading to cellular damage and death. The CDC’s Stance on Hydrogen Peroxide… The CDC recognizes hydrogen peroxide as an effective disinfectant against a broad spectrum of microorganisms. It is listed as a sterilant and high-level disinfectant, capable of inactivating bacteria, viruses, spores, yeast, and fungi. The CDC recommends its use in healthcare settings for sterilizing medical instruments and surfaces due to its efficacy and safety profile. sciencedirect.com/science/articl…


SATURDAY SCIENCE FIX: “The egg that wasn’t was, then wasn’t” 🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔 (No, not a grammar error 👆)



